Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community
The present invention relates to a bacterial strain capable of serving as a biomarker for alcoholic fatty liver and a pharmaceutical composition for preventing or treating alcoholic fatty liver, a food composition for preventing or alleviating alcoholic fatty liver, or a probiotics composition for p...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a bacterial strain capable of serving as a biomarker for alcoholic fatty liver and a pharmaceutical composition for preventing or treating alcoholic fatty liver, a food composition for preventing or alleviating alcoholic fatty liver, or a probiotics composition for preventing or alleviating alcoholic fatty liver, each composition comprising the bacterial strain asan effective ingredient.
本发明涉及能够用作酒精性脂肪肝的生物标志物的细菌菌株,以及用于预防或治疗酒精性脂肪肝的药物组合物、用于预防或改善酒精性脂肪肝的食品组合物或用于预防或改善酒精性脂肪肝的益生菌组合物,每种组合物包含所述细菌菌株作为有效成分。 |
---|